Konfident302

Application to investigate the safety of KVD900 for treatment of HAE attacks.

The Konfident302 clinical trial app is designed to enable participants to complete study assessments easily and from their own mobile device. Access is restricted to registered participants in possession of a valid activation code. The app does not provide medical advice. Please consult with your study doctor with any questions or concerns you may have regarding your individual needs or medical conditions or any related questions about your participation in the study.